S. Asenbaum

7.1k total citations
105 papers, 5.1k citations indexed

About

S. Asenbaum is a scholar working on Cellular and Molecular Neuroscience, Neurology and Psychiatry and Mental health. According to data from OpenAlex, S. Asenbaum has authored 105 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cellular and Molecular Neuroscience, 30 papers in Neurology and 23 papers in Psychiatry and Mental health. Recurrent topics in S. Asenbaum's work include Neurotransmitter Receptor Influence on Behavior (20 papers), Neurological disorders and treatments (20 papers) and Parkinson's Disease Mechanisms and Treatments (17 papers). S. Asenbaum is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (20 papers), Neurological disorders and treatments (20 papers) and Parkinson's Disease Mechanisms and Treatments (17 papers). S. Asenbaum collaborates with scholars based in Austria, Germany and Sweden. S. Asenbaum's co-authors include Walter Pirker, Thomas Brücke, I. Podreka, Siegfried Kasper, J. Tauscher, P. Angelberger, Klaus Tatsch, T. Br�cke, Matthäus Willeit and Alexander Neumeister and has published in prestigious journals such as NeuroImage, Neurology and Cancer.

In The Last Decade

S. Asenbaum

102 papers receiving 4.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Asenbaum Austria 42 1.9k 1.7k 968 964 928 105 5.1k
Andrea Varrone Sweden 43 1.9k 1.0× 1.7k 1.0× 1.7k 1.8× 923 1.0× 982 1.1× 189 6.1k
Beatriz Gómez‐Ansón Spain 40 1.6k 0.8× 727 0.4× 841 0.9× 692 0.7× 1.1k 1.2× 110 4.3k
Hans Clusmann Germany 40 1.4k 0.7× 2.2k 1.3× 503 0.5× 2.8k 2.9× 915 1.0× 218 5.7k
Seth P. Finklestein United States 48 1.6k 0.9× 1.8k 1.1× 1.3k 1.3× 553 0.6× 1.3k 1.4× 111 8.0k
Éric Guedj France 38 1.3k 0.7× 515 0.3× 947 1.0× 1.7k 1.7× 1.6k 1.8× 195 4.9k
Jamie L. Eberling United States 37 1.4k 0.8× 1.5k 0.9× 465 0.5× 791 0.8× 932 1.0× 77 4.4k
Peter Bartenstein Germany 38 740 0.4× 839 0.5× 1.1k 1.2× 773 0.8× 810 0.9× 62 3.7k
Alexander Gerhard United Kingdom 37 2.2k 1.1× 1.7k 1.0× 656 0.7× 709 0.7× 346 0.4× 86 5.8k
I. Podreka Austria 35 1.1k 0.6× 884 0.5× 599 0.6× 719 0.7× 1.1k 1.2× 84 3.2k
David F. Tang‐Wai Canada 36 1.9k 1.0× 795 0.5× 554 0.6× 1.6k 1.6× 1.6k 1.7× 125 5.0k

Countries citing papers authored by S. Asenbaum

Since Specialization
Citations

This map shows the geographic impact of S. Asenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Asenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Asenbaum more than expected).

Fields of papers citing papers by S. Asenbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Asenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Asenbaum. The network helps show where S. Asenbaum may publish in the future.

Co-authorship network of co-authors of S. Asenbaum

This figure shows the co-authorship network connecting the top 25 collaborators of S. Asenbaum. A scholar is included among the top collaborators of S. Asenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Asenbaum. S. Asenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Widhalm, Georg, Stefan Wolfsberger, Georgi Minchev, et al.. (2010). 5‐Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement. Cancer. 116(6). 1545–1552. 168 indexed citations
2.
Assem‐Hilger, Eva, Rupert Lanzenberger, Markus Savli, et al.. (2010). Central serotonin 1A receptor binding in temporal lobe epilepsy: A [carbonyl-11C]WAY-100635 PET study. Epilepsy & Behavior. 19(3). 467–473. 29 indexed citations
3.
Zitterl, Werner, Thomas Stompe, Martin Aigner, et al.. (2009). Diencephalic Serotonin Transporter Availability Predicts Both Transporter Occupancy and Treatment Response to Sertraline in Obsessive-Compulsive Checkers. Biological Psychiatry. 66(12). 1115–1122. 11 indexed citations
4.
Pötzi, Christian, Alexander Becherer, Christine Marosi, et al.. (2007). [11C] Methionine and [18F] Fluorodeoxyglucose PET in the follow-up of glioblastoma multiforme. Journal of Neuro-Oncology. 84(3). 305–14. 36 indexed citations
5.
Tatsch, Klaus, S. Asenbaum, Peter Bartenstein, et al.. (2002). European Association of Nuclear Medicine procedure guidelines for brain perfusion SPET using (99m)Tc-labelled radiopharmaceuticals.. PubMed. 29(10). BP36–42. 53 indexed citations
6.
Tatsch, Klaus, S. Asenbaum, P. Bartenstein, et al.. (2002). European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) receptor ligands.. PubMed. 29(10). BP23–5. 56 indexed citations
7.
Bartenstein, P., S. Asenbaum, A. Catafau, et al.. (2002). European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG.. PubMed. 29(10). BP43–8. 42 indexed citations
8.
Kasper, Siegfried, J. Tauscher, Matthäus Willeit, et al.. (2002). Receptor and Transporter Imaging Studies in Schizophrenia, Depression, Bulimia and Tourette's Disorder—Implications for Psychopharmacology-. The World Journal of Biological Psychiatry. 3(3). 133–146. 72 indexed citations
9.
Tribl, Gotthard G., J. Zeitlhofer, S. Asenbaum, et al.. (2002). Sequential MRI in a case of Creutzfeldt-Jakob disease. Neuroradiology. 44(3). 223–226. 28 indexed citations
10.
Stamenković, M., Shird Schindler, S. Asenbaum, et al.. (2001). No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette’s disorder patients: a [123I]-β-CIT SPECT-study. European Neuropsychopharmacology. 11(1). 69–74. 38 indexed citations
11.
Pirker, Walter, et al.. (2000). [123I]?-CIT spect in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Movement Disorders. 15(6). 1158–1167. 157 indexed citations
12.
Pirker, Walter, Christoph Baumgartner, Stefan Brugger, et al.. (1999). Severe akinetic syndrome resulting from a bilateral basal ganglia lesion following bone marrow transplantation. Movement Disorders. 14(3). 525–528. 1 indexed citations
13.
Wöber, Christian, J. Zeitlhofer, S. Asenbaum, et al.. (1998). Monitoring of Median Nerve Somatosensory Evoked Potentials in Carotid Surgery. Journal of Clinical Neurophysiology. 15(5). 429–438. 22 indexed citations
14.
Küfferle, B., J. Tauscher, C Veselý, et al.. (1996). Striatal dopamine-2 receptor occupancy in psychotic patients treated with risperidone. Psychiatry Research Neuroimaging. 68(1). 23–30. 27 indexed citations
15.
Oder, W., T. Br�cke, H. Kollegger, et al.. (1996). Dopamine D2 receptor binding is reduced in Wilson's disease: Correlation of neurological deficits with striatal123I-Iodobenzamide binding. Journal of Neural Transmission. 103(8-9). 1093–1103. 22 indexed citations
16.
Kornhuber, Johannes, T. Br�cke, P. Angelberger, S. Asenbaum, & I. Podreka. (1995). SPECT imaging of dopamine receptors with [123I]epidepride: characterization of uptake in the human brain. Journal of Neural Transmission. 101(1-3). 95–103. 29 indexed citations
17.
Pirker, Walter, S. Asenbaum, Siegfried Kasper, et al.. (1995). ?-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo. Journal of Neural Transmission. 100(3). 247–256. 101 indexed citations
18.
Schima, Wolfgang, et al.. (1993). Bedeutung der Magnetfeldstärke in der MR-Diagnostik der multiplen Sklerose: Ein Vergleich von 0,5 und 1,5 T. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 158(4). 368–371. 16 indexed citations
19.
Zeitlhofer, J., S. Asenbaum, C. K. Spiss, et al.. (1993). Central nervous system function after cardiopulmonary bypass. European Heart Journal. 14(7). 885–890. 38 indexed citations
20.
Brücke, Thomas, S. Wenger, I. Podreka, & S. Asenbaum. (1991). Dopamine receptor classification, neuroanatomical distribution and in vivo imaging.. PubMed. 103(21). 639–46. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Varrone Breakdown of academic impact, for papers by Beatriz Gómez‐Ansón Breakdown of academic impact, for papers by Hans Clusmann Breakdown of academic impact, for papers by Seth P. Finklestein Breakdown of academic impact, for papers by Éric Guedj Breakdown of academic impact, for papers by Jamie L. Eberling Breakdown of academic impact, for papers by Peter Bartenstein Breakdown of academic impact, for papers by Alexander Gerhard Breakdown of academic impact, for papers by I. Podreka Breakdown of academic impact, for papers by David F. Tang‐Wai
Rankless by CCL
2026